相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Monocarboxylate transporter 1 is an independent prognostic factor in esophageal squamous cell carcinoma
Xue Chen et al.
ONCOLOGY REPORTS (2019)
Clinical significance of metabolism-related biomarkers in non-Hodgkin lymphoma-MCT1 as potential target in diffuse large B cell lymphoma
Julieta Afonso et al.
CELLULAR ONCOLOGY (2019)
The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma
Damien Ambrosetti et al.
PLOS ONE (2018)
MCT1 regulates aggressive and metabolic phenotypes in bladder cancer
Guiming Zhang et al.
JOURNAL OF CANCER (2018)
WNT6 is a novel oncogenic prognostic biomarker in human glioblastoma
Celine S. Goncalves et al.
THERANOSTICS (2018)
Monocarboxylate transporter 1 is a key player in glioma-endothelial cell crosstalk
Vera Miranda-Goncalves et al.
MOLECULAR CARCINOGENESIS (2017)
Value of pH regulators in the diagnosis, prognosis and treatment of cancer
Sara Granja et al.
SEMINARS IN CANCER BIOLOGY (2017)
Metabolic alterations underlying Bevacizumab therapy in glioblastoma cells
Vera Miranda-Goncalves et al.
ONCOTARGET (2017)
Monocarboxylate Transporter 1 (MCT1) is an independent prognostic biomarker in endometrial cancer
Ayse Latif et al.
BMC CLINICAL PATHOLOGY (2017)
A first-in-human first-in-class (FIC) trial of the monocarboxylate transporter 1 (MCT1) inhibitor AZD3965 in patients with advanced solid tumours.
Sarah E. R. Halford et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Lactate Transporters and pH Regulation: Potential Therapeutic Targets in Glioblastomas
Vera Miranda-Goncalves et al.
CURRENT CANCER DRUG TARGETS (2016)
Inhibition of monocarboxylate transporter 1 suppresses the proliferation of glioblastoma stem cells
Tetsuya Takada et al.
JOURNAL OF PHYSIOLOGICAL SCIENCES (2016)
Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas
Vera Miranda-Goncalves et al.
ONCOTARGET (2016)
Monocarboxylate transport inhibition potentiates the cytotoxic effect of 5-fluorouracil in colorectal cancer cells
Ricardo Amorim et al.
CANCER LETTERS (2015)
Cancer stem cells in glioblastoma
Justin D. Lathia et al.
GENES & DEVELOPMENT (2015)
Glioblastoma multiforme: Pathogenesis and treatment
Constantinos Alifieris et al.
PHARMACOLOGY & THERAPEUTICS (2015)
A transcriptomic signature mediated by HOXA9 promotes human glioblastoma initiation, aggressiveness and resistance to temozolomide
Marta Pojo et al.
ONCOTARGET (2015)
Targeting lactate transport suppresses in vivo breast tumour growth
Filipa Morais-Santos et al.
ONCOTARGET (2015)
Activity of the Monocarboxylate Transporter 1 Inhibitor AZD3965 in Small Cell Lung Cancer
Radoslaw Polanski et al.
CLINICAL CANCER RESEARCH (2014)
Differential sensitivities to lactate transport inhibitors of breast cancer cell lines
Filipa Morais-Santos et al.
ENDOCRINE-RELATED CANCER (2014)
Integrated analysis identifies different metabolic signatures for tumor-initiating cells in a murine glioblastoma model
Isako Saga et al.
NEURO-ONCOLOGY (2014)
Cancer metabolism: Key players in metabolic reprogramming
Tomoyoshi Soga
CANCER SCIENCE (2013)
The SLC16 gene family - Structure, role and regulation in health and disease
Andrew P. Halestrap
MOLECULAR ASPECTS OF MEDICINE (2013)
Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets
Vera Miranda-Goncalves et al.
NEURO-ONCOLOGY (2013)
Patient-Specific Orthotopic Glioblastoma Xenograft Models Recapitulate the Histopathology and Biology of Human Glioblastomas In Situ
Kyeung Min Joo et al.
CELL REPORTS (2013)
Molecular mechanisms of temozolomide resistance in glioblastoma multiforme
Tor-Christian Aase Johannessen et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2012)
The monocarboxylate transporter familyuRole and regulation
Andrew P. Halestrap et al.
IUBMB LIFE (2012)
Role of monocarboxylate transporters in human cancers: state of the art
Celine Pinheiro et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2012)
Targeting the Lactate Transporter MCT1 in Endothelial Cells Inhibits Lactate-Induced HIF-1 Activation and Tumor Angiogenesis
Pierre Sonveaux et al.
PLOS ONE (2012)
Astrocyte-Neuron Lactate Transport Is Required for Long-Term Memory Formation
Akinobu Suzuki et al.
CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Metabolic Targeting of Lactate Efflux by Malignant Glioma Inhibits Invasiveness and Induces Necrosis: An In Vivo Study
Chaim B. Colen et al.
NEOPLASIA (2011)
EORTC study 26041-22041: Phase I/II study on concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) with PTK787/ZK222584 (PTK/ZK) in newly diagnosed glioblastoma
Alba A. Brandes et al.
EUROPEAN JOURNAL OF CANCER (2010)
Tumor metabolism of lactate: the influence and therapeutic potential for MCT and CD147 regulation
Kelly M. Kennedy et al.
FUTURE ONCOLOGY (2010)
An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patients
Francois Ducray et al.
MOLECULAR CANCER (2010)
Targeting Metabolic Remodeling in Glioblastoma Multiforme
Amparo Wolf et al.
ONCOTARGET (2010)
Intrinsic Gene Expression Profiles of Gliomas Are a Better Predictor of Survival than Histology
Lonneke A. M. Gravendeel et al.
CANCER RESEARCH (2009)
18F-FDG Uptake in Lung, Breast, and Colon Cancers: Molecular Biology Correlates and Disease Characterization
Hossein Jadvar et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Rembrandt: Helping Personalized Medicine Become a Reality through Integrative Translational Research
Subha Madhavan et al.
MOLECULAR CANCER RESEARCH (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age
Yohan Lee et al.
BMC MEDICAL GENOMICS (2008)
Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice
Pierre Sonveaux et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Stem cell-related Self-Renewal signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma
Anastasia Murat et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Causes and consequences of increased glucose metabolism of cancers
Robert J. Gillies et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis
Ralph J. DeBerardinis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Metabolic remodeling of malignant gliomas for enhanced sensitization during radiotherapy: An in vitro study
Chaim B. Colen et al.
NEUROSURGERY (2006)
The SLC16 gene family -: from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond
AP Halestrap et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2004)
Silencing of monocarboxylate transporters via small interfering ribonucleic acid inhibits glycolysis and induces cell death in malignant glioma: An in vitro study
SP Mathupala et al.
NEUROSURGERY (2004)
Why do cancers have high aerobic glycolysis?
RA Gatenby et al.
NATURE REVIEWS CANCER (2004)
Molecular features, regulation, and function of monocarboxylate transporters: Implications for drug delivery
BE Enerson et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2003)
Expression of monocarboxylate transporter MCTI in normal and neoplastic human CNS tissues
MK Froberg et al.
NEUROREPORT (2001)
分享论文
